1. Home
  2. PHAR vs HKD Comparison

PHAR vs HKD Comparison

Compare PHAR & HKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • HKD
  • Stock Information
  • Founded
  • PHAR 1988
  • HKD 2003
  • Country
  • PHAR Netherlands
  • HKD France
  • Employees
  • PHAR N/A
  • HKD N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • HKD Finance: Consumer Services
  • Sector
  • PHAR Health Care
  • HKD Finance
  • Exchange
  • PHAR Nasdaq
  • HKD Nasdaq
  • Market Cap
  • PHAR 618.3M
  • HKD 503.4M
  • IPO Year
  • PHAR N/A
  • HKD 2022
  • Fundamental
  • Price
  • PHAR $8.42
  • HKD $2.62
  • Analyst Decision
  • PHAR Strong Buy
  • HKD
  • Analyst Count
  • PHAR 3
  • HKD 0
  • Target Price
  • PHAR $27.00
  • HKD N/A
  • AVG Volume (30 Days)
  • PHAR 5.6K
  • HKD 254.0K
  • Earning Date
  • PHAR 03-13-2025
  • HKD 01-01-0001
  • Dividend Yield
  • PHAR N/A
  • HKD N/A
  • EPS Growth
  • PHAR N/A
  • HKD N/A
  • EPS
  • PHAR N/A
  • HKD 0.33
  • Revenue
  • PHAR $285,745,000.00
  • HKD $27,776,448.00
  • Revenue This Year
  • PHAR $20.08
  • HKD N/A
  • Revenue Next Year
  • PHAR $9.22
  • HKD N/A
  • P/E Ratio
  • PHAR N/A
  • HKD $7.90
  • Revenue Growth
  • PHAR 30.64
  • HKD N/A
  • 52 Week Low
  • PHAR $6.65
  • HKD $2.55
  • 52 Week High
  • PHAR $13.20
  • HKD $5.80
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 40.05
  • HKD 44.49
  • Support Level
  • PHAR $7.95
  • HKD $2.57
  • Resistance Level
  • PHAR $9.35
  • HKD $2.82
  • Average True Range (ATR)
  • PHAR 0.52
  • HKD 0.12
  • MACD
  • PHAR -0.16
  • HKD 0.00
  • Stochastic Oscillator
  • PHAR 22.76
  • HKD 18.47

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About HKD AMTD Digital Inc. (every five of which represent two)

AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. The company integrates various digital businesses using its AMTD SpiderNet ecosystem. Its reportable segments are; digital solutions services financial services; digital solutions services non-financial services, hotel operations, hospitality and VIP services, digital media, content and marketing services, and others. The company generates maximum revenue by providing financial digital solutions through its AMTD Risk Solutions, a digital insurance brokerage platform, and PolicyPal which is a digital insurance technology platform. Geographically, the company generates maximum revenue from Hong Kong and the rest from Canada and Singapore.

Share on Social Networks: